Our Webinars

Assessing the Competition in Rare Disease Clinical Trials: The Need for a Thorough Feasibility Strategy

Assessing the Competition in Rare Disease Clinical Trials: Need for a Thorough Feasibility Strategy

Date: Tuesday, March 10, 2020
Time: 11am EDT(NA) / 3pm GMT (UK) / 4pm CET (EU-Central)
Length: 60 minutes

REGISTER

When planning a rare disease clinical trial, drug developers can expect to face several challenges. In many cases, developers approach the study believing that patient recruitment will be their biggest obstacle. They are correct in making this assumption, but it is not always for the reasons they assumed.

Finding patients is, in fact, the most common obstacle experienced in rare disease clinical trials. Nevertheless, it is not always due to lack of patient presence, rather it is the culmination of several key challenges. This includes but is not limited to understanding the diagnostic odyssey, competitive study and treatment landscape, ability to operationalize at the global, regional and site level. This is where a robust, data-driven feasibility analysis becomes a necessary, key component.

This webinar will provide an in-depth perspective from the experts developing the most innovative feasibility strategies being applied to the rare diseases of today.

Presenters:

  • Lisa Dilworth, BS, MS, Vice President Rare, Orphan and Pediatric Diseases, Synteract
  • Rachael Young, Associate Director, Feasibility, Synteract


Looking for a previous webinar? Go to our Webinars Archive arrow
x

Submit RFI / RFP

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Contact Synteract

Tell us how to stay in touch with you:

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

Required

x

Synteract General Medicince Clinical Trial Leadership

Linda RawlingsContact us to find out more about our General Medicine expertise and experience

Linda Rawlings, MSc, FIBMS
VP General Medicine

Contact us to find out more about our General Medicine expertise and experience
x

Synteract Rare, Orphan, & Pediatric Diseases Clinical Trial Leadership

Lisa DilworthContact us to find out more about our Pediatric and Rare and Orphan Diseases expertise and experience

Lisa Dilworth
VP, Rare, Orphan, & Pediatrics

Contact us to find out more about our Rare, Orphan, & Pediatric Diseases expertise and experience
x

 

x

Download Resource

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required

x

To complete your download, please choose an option in the Internet Explorer pop-up window at the bottom of this browser.

x

Opt In

By submitting your information to us through this webform, your business details will be added to our database. In accordance with our Privacy Notice, we may then contact you with marketing information about Synteract that might be of interest to you. We will never sell your details to third parties. You can unsubscribe from marketing communications at any time.

*Required